Viewing Study NCT00006368


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-04-04 @ 1:39 PM
Study NCT ID: NCT00006368
Status: COMPLETED
Last Update Posted: 2013-05-01
First Post: 2000-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
None Breast Cancer View
None Gastrointestinal Carcinoid Tumor View
None Islet Cell Tumor View
None Lung Cancer View
None Lymphoma View
None Melanoma (Skin) View
None Neoplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV adult Hodgkin lymphoma View
None stage IV breast cancer View
None recurrent breast cancer View
None recurrent non-small cell lung cancer View
None recurrent adult Hodgkin lymphoma View
None extensive stage small cell lung cancer View
None recurrent small cell lung cancer View
None metastatic gastrointestinal carcinoid tumor View
None recurrent gastrointestinal carcinoid tumor View
None gastrinoma View
None recurrent adult brain tumor View
None insulinoma View
None recurrent islet cell carcinoma View
None ACTH-producing pituitary tumor View
None prolactin-producing pituitary tumor View
None growth hormone-producing pituitary tumor View
None recurrent pituitary tumor View
None TSH producing pituitary tumor View
None nonfunctioning pituitary tumor View
None adult brain stem glioma View
None adult craniopharyngioma View
None adult medulloblastoma View
None adult meningioma View
None adult glioblastoma View
None stage IV melanoma View
None recurrent melanoma View
None stage IV non-small cell lung cancer View
None WDHA syndrome View
None somatostatinoma View
None pancreatic polypeptide tumor View
None glucagonoma View
None pulmonary carcinoid tumor View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV adult Burkitt lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None adult anaplastic astrocytoma View
None adult myxopapillary ependymoma View
None adult anaplastic ependymoma View
None adult anaplastic oligodendroglioma View
None adult central nervous system germ cell tumor View
None adult pilocytic astrocytoma View
None adult subependymoma View
None adult ependymoblastoma View
None adult pineocytoma View
None adult pineoblastoma View
None adult meningeal hemangiopericytoma View
None stage IV mantle cell lymphoma View
None recurrent mantle cell lymphoma View
None adult choroid plexus tumor View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View
None adult grade III meningioma View
None adult giant cell glioblastoma View
None adult gliosarcoma View